UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus

Emerging infectious diseases, 2015-06, Vol.21 (6), p.1041-1044

2015

Volltextzugriff (PDF)

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

Clinical microbiology and infection, 2020-11, Vol.26 (11), p.1464-1472

2020

Volltextzugriff (PDF)

Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes

Journal of antimicrobial chemotherapy, 2022-03, Vol.77 (4), p.1212-1213

2022

Volltextzugriff (PDF)

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates

Clinical microbiology and infection, 2019-06, Vol.25 (6), p.681-687

2019

Volltextzugriff (PDF)

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.5836-5842

2013

Volltextzugriff (PDF)

Estimated burden of fungal infections in Sweden

Mycoses, 2019-11, Vol.62 (11), p.1043-1048

2019

Volltextzugriff (PDF)

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

Journal of antimicrobial chemotherapy, 2009-10, Vol.64 (4), p.786-793

2009

Volltextzugriff (PDF)

CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection

Tuberculosis (Edinburgh, Scotland), 2020-07, Vol.123, p.101959-101959, Article 101959

2020

Volltextzugriff (PDF)

Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections

Journal of Clinical Microbiology, 2010-05, Vol.48 (5), p.1853-1858

2010

Volltextzugriff (PDF)

Candidaemia in Sweden: a nationwide prospective observational survey

Clinical microbiology and infection, 2013-04, Vol.19 (4), p.E218-E221

2013

Volltextzugriff (PDF)

Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?

Journal of antimicrobial chemotherapy, 2013-09, Vol.68 (9), p.2074-2077

2013

Volltextzugriff (PDF)

Histoplasmosis in Europe: Report on an epidemiological survey from the European Confederation of Medical Mycology Working Group

Medical mycology (Oxford), 2008-01, Vol.46 (1), p.57-65

2008

Volltextzugriff (PDF)

Trends in Antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998 : Comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method

Journal of clinical microbiology, 2001-11, Vol.39 (11), p.4181-4183

CHRYSSANTHOU, Erja

2001

Volltextzugriff (PDF)

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis

The international journal of tuberculosis and lung disease, 2011-04, Vol.15 (4), p.502-509

2011

Volltextzugriff (PDF)

Malassezia pachydermatis fungaemia in a neonatal intensive care unit

Acta pædiatrica (Oslo), 2001-03, Vol.90 (3), p.323-327

2001

Volltextzugriff (PDF)

Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp

Clinical microbiology and infection, 2006-09, Vol.12 (9), p.901-904

2006

Volltextzugriff (PDF)

Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts

Clinical microbiology and infection, 2003-08, Vol.9 (8), p.i-viii

2003

Volltextzugriff (PDF)

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

Journal of antimicrobial chemotherapy, 2010-05, Vol.65 (5), p.946-952

2010

Volltextzugriff (PDF)

Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia

Journal of antimicrobial chemotherapy, 2008-06, Vol.61 (6), p.1309-1311

2008

Volltextzugriff (PDF)

Malassezia pachydermatis fungaemia in a neonatal intensive care unit

Acta Paediatrica, 2001-03, Vol.90 (3), p.323-327

2001

Volltextzugriff (PDF)

Minimum inhibitory concentration distributions for Mycobacterium avium complex—towards evidence-based susceptibility breakpoints

International journal of infectious diseases, 2017-02, Vol.55 (C), p.122-124

2017

Volltextzugriff (PDF)

Occurrence of yeasts in faecal samples from Antarctic and South American seabirds

Mycoses, 2011-11, Vol.54 (6), p.e811-e815

2011

Volltextzugriff (PDF)

Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)

Clinical microbiology and infection, 2003-06, Vol.9 (6), p.467-474

2003

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(88)
Medicin Och Hälsovetenskap
(78)
Humans
(64)
Infectious Diseases
(60)
Microbiology
(50)
Biological And Medical Sciences
(43)
Medical Sciences
(39)
Antifungal Agents - Pharmacology
(34)
Male
(26)
Female
(23)
Pharmacology. Drug Treatments
(23)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(22)
Mycology
(21)
Antifungal Agents
(20)
Middle Aged
(19)
Microbial Sensitivity Tests - Methods
(18)
Pharmacology & Pharmacy
(18)
Microbial Sensitivity Tests
(17)
Adult
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods

Estimated burden of fungal infections in Sweden

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection

Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections

Candidaemia in Sweden: a nationwide prospective observational survey

Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?

Histoplasmosis in Europe: Report on an epidemiological survey from the European Confederation of Medical Mycology Working Group

Trends in Antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998 : Comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis

Malassezia pachydermatis fungaemia in a neonatal intensive care unit

Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp

Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia

Malassezia pachydermatis fungaemia in a neonatal intensive care unit

Minimum inhibitory concentration distributions for Mycobacterium avium complex—towards evidence-based susceptibility breakpoints

Occurrence of yeasts in faecal samples from Antarctic and South American seabirds

Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)

Suchergebnisse filtern